Literature DB >> 28395745

Establishment of MUi009 - A human induced pluripotent stem cells from a 32year old male with homozygous β°-thalassemia coinherited with heterozygous α-thalassemia 2.

Wasinee Wongkummool1, Warun Maneepitasut2, Pirut Tong-Ngam3, Amornrat Tangprasittipap4, Thongperm Munkongdee5, Chanikarn Boonchuay6, Saovaros Svasti7, Narisorn Kitiyanant3, Kittiphong Paiboonsukwong5, Suthat Fucharoen5, Alisa Tubsuwan8.   

Abstract

The thalassemias are a group of genetic disorders characterized by a deficiency in the synthesis of globin chains. In this study the MUi009-A human induced pluripotent stem cell line was successfully generated from peripheral blood CD34+ haematopoietic progenitors of a 32year old male who had coinherited a homozygous β°-thalassemia mutation at codon 41/42 (-TCTT) and a heterozygous α-thalassemia 4.2 deletion. The MUi009-A cell line exhibited embryonic stem cell characteristics with consistent pluripotency marker expression and the capability of differentiating into the three germ layers. The cell line may provide a tool for drug testing and gene therapy studies.
Copyright © 2017 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28395745     DOI: 10.1016/j.scr.2017.02.012

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  1 in total

Review 1.  Emerging Therapies.

Authors:  Amaliris Guerra; Khaled M Musallam; Ali T Taher; Stefano Rivella
Journal:  Hematol Oncol Clin North Am       Date:  2017-12-15       Impact factor: 3.722

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.